Page 3 - Patanjali

IPL 2020 title sponsorship: Tata, Jio, Patanjali among firms in the fray

Unacademy, Patanjali also among Indian contenders; Byju's and Dream11 too enter bids

IPL 2020: BCCI invites bids for title sponsorship rights by Friday

The rights would be available for the August 18-December 31, 2020 period, and the bids would be opened by August 18, it said

Madras HC maintains injunction barring Patanjali from using term Coronil

Court came down heavily on Patanjali for attempting to make profits by exploiting fear of Covid-19

Baba Ramdev to set up gurukul on vedic culture and yoga in Ayodhya

This would Ramdev's first such facility in Uttar Pradesh

Coronavirus vaccine update: Moderna vaccine trial delayed, India's by Aug15

Coronavirus vaccine latest update: A large trial of Moderna Inc's potential coronavirus vaccine has been delayed, as the company makes changes to its study plan. Catch latest updates on Covid vaccine

Coronil: Patanjali can sell its drug, but not as a cure for Covid-19

AYUSH Ministry has only given permission to sell this particular formulation as immunity booster and not as a medicinal cure for Covid-19

From Patanjali's claim to U-turn on Coronil: Sequence of events

On June 23, Baba Ramdev-led Patanjali Ayurved launched a medicine, 'Coronil', for treating Covid-19 in just seven days

Ruchi Soya soared 90 times in 5 months; should you buy?

From Rs 16.9 to Rs 1,519 in five months, the stock has seen a spectacular rise of 8,988 per cent

Coronavirus updates: Over 17,000 new cases, record recoveries in India

India death toll crosses 15,000; Maharashtra, Delhi, Tamil Nadu account for 68% of cases added today

Followed all procedures to manufacture Covid-19 medicine: Balkrishna

This comes after MoS for the Union Ayush Ministry Shripad Naik said that Patanjali Ayurved should not have advertised its newly-launched ayurvedic drugs for Covid-19 before getting final approvals

Top headlines: Sebi on insider trading, pvt investment in space research

Business Standard brings to you top stories of the day which made it to the headlines

Coronil is no kadha: Patanjali's Covid-19 drug must go through scrutiny

Baba Ramdev's creations to fight Covid must go through the rigours of scientific verification and clinical trials before being sold in the market

India-US 'green' corridor for air travel, and other coronavirus updates

The total number of Covid-19 cases in Delhi crossed the 66,000 mark, with the biggest single-day spike of 3,947 fresh infections being reported on Tuesday

Watchdog flags 50 ad campaigns by drug makers offering Covid-19 cure

The body also made public the list of the 50 companies which were found to have advertised about COVID-19 cure or prevention in April

India tally rises to 440K; Patanjali launches ayurvedic drug for Covid-19

According to government data, the situation in India is not as alarming as some of the other countries, given a limited spread on a per-capita basis

Patanjali to launch ayurvedic drug for Covid-19, claims cure within 14 days

Balkrishna had earlier this month claimed that an Ayurvedic medicine developed by the company has been able to cure Covid-19 patients within 5-14 days

Patanjali finds coronavirus cure in Ayurveda; claims 100% favourable result

We are not talking about an immunity booster. We are talking about a cure," said Acharya Balkrishna, managing director of Patanjali

Patanjali to issue debentures worth Rs 250 cr; bidding to start on May 28

NCDs will carry a coupon rate of 10.10 per cent with a tenure of three years

After acquiring Ruchi Soya, Ramdev's Patanjali aims to beat HUL in sales

Haridwar-based group has given itself a 2-year target for doing so

Patanjali secures Rs 3,200 cr loan from SBI, other banks to buy Ruchi Soya

Patanjali said it has got loans of Rs 1,200 crore from SBI, Rs 700 crore from PNB, Rs 600 crore from UBI, Rs 400 crore from Syndicate Bank and Rs 300 crore from Allahabad Bank